🇱🇰 Country Profile

Sri Lanka

Expanding pharmaceutical supply to Sri Lanka

🇱🇰 $318M
All data from DGCIS India export records (fiscal year, April–March).
$318M
Scale
Sri Lanka's patients receive $318M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
86%
Medicine
Overwhelmingly finished medicines, drug formulations account for 86% of shipments.
2.0×
Trajectory
India's pharmaceutical supply to Sri Lanka has grown 2.0× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Sri Lanka, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $274M (86.1%) Medicine Ingredients $23.4M (7.4%) Surgical & Hospital Supplies $12.4M (3.9%) Vaccines $4.5M (1.4%) Traditional & Herbal $4.0M (1.3%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Sri Lanka Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Sri Lanka: $1.6M across 8 filings (2011-2024).